Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

Not Applicable

Not yet recruiting

• Conditions: Breast Cancer; Prostate Cancer; Lung Cancer; Gynaecologic Cancer; Colorectal Cancer; Pancreatic Cancer Metastatic

• Registration Number: NCT07201194
• Lead Sponsor: Vejle Hospital

Brief Summary

The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone.

A total of 90 patients experiencing chemotherapy induced nausea will be allocated 1:1 to either acupuncture and antiemetic medicine or antiemetic medicine alone.

The level of nausea and other cancer related symptoms will be assessed at baseline and 8 and 22 days after enrollment

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-09
• Study First Submitted: 2025-09-23
• Study First Submitted QC: 2025-09-23
• Last Update Submitted: 2025-09-23
• Study Start: 2025-10-01
• Study First Posted: 2025-10-01
• Last Update Posted: 2025-10-01
• Primary Completion: 2026-04
• Study Completion: 2026-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Not provided

Exclusion Criteria

• Brain metastases
• Performance status >2

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Patient reported nausea assessed on the EORTC-15-PAL Scale	8 days after enrollment

Secondary Outcome Measures

Name	Time	Method
Patient reported symptom intensity according to the EORTC-15 PAL Scale	8 and 22 days after enrollment

Trial Locations

Locations (1)

Department of Oncology, Vejle Hospital; 🇩🇰 Vejle, Denmark